Overview Preoperative Chemoradiation for Glioblastoma Status: Completed Trial end date: 2015-07-01 Target enrollment: Participant gender: Summary Trial to determine the safety of neoadjuvant treatment with concurrent temozolomide and radiation therapy, followed by surgery and then further temozolomide. Phase: Phase 1 Details Lead Sponsor: Tampa General HospitalTreatments: DacarbazineTemozolomide